Bayer Strengthens Research and Development
Pharmaceutical pipeline is well filled, with 50 projects currently in phases I to III of clinical testing
16-Dec-2008 -
The Bayer Group is to further expand its research and development activities despite the current financial and economic crisis. “The task now is to set the right course. Only through innovation can our company generate the growth that is essential to safeguard its sustained success,” said Werner ...
carbon nanotubes
chlorine
climate change
+19